Friday, November 20, 2015

In The 1930's Dr. Royal Rife's Oscillating Rife Beam Destroyed Cancer. And, The AMA Destroyed Dr. Rife



Did YOU Know...

A Proven Cure For Cancer Was Discovered in the 1930's?

Dr, Royal Rife's "most controversial claim was that his device could kill the virus-like organisms responsible for cancer. Rife and his team claimed to have cured 15 "hopeless" cancer patients after 60 days' treatment.

Rife's ray tube system was installed in several clinics and his results were corroborated by numerous scientists and doctors. In 1939 he was invited to address the ROYAL SOCIETY OF MEDICINE, which had a APPROVED his FINDINGS, and he subsequently formed the Rife Ray Beam Tube Corporation, to build models for hospitals and clinics.

But with the death of one of his key supporters, Rife found himself under sudden and prolonged assault from the AMERICAN MEDICAL ASSOCIATION (Dun-Dun-Duuuuunnnn!), who banned use of his beam ray to treat patients.

Within a year the dream was over, Rife a broken man.

To this day it remains unclear why the AMA turned on Rife, a pharmaceutical conspiracy being an obvious, if paranoid conclusion."

"... it remains unclear why the AMA turned on Rife..."?  Er, not so much.

The TRUTH: It's 'Sandbox' Simple: Follow The Money:

Just Ask Yourself:

1.) Who Had The Most To GAIN If Cancer was Cured?  And...

2.) Who Had The Most To LOSE If Cancer Was Cured?

Answer: Cancer Treatment is a multi-billion dollar business.

And, those for-profit, multi-national pharmaceutical companies making billions of dollars manufacturing cancer-drug TREATMENTS wouldn't make a DIME if Cancer were CURED.

Dr Royal Rife's Cancer-Killing Oscillating Beam Ray

No comments:

Post a Comment

Greetings From San Francisco!
Thanks For Reading Forget Big Brother...
I hope you find something herein that is informative, inspires interest, laughter, action and provides you with Gifts of Unknown Things.
Feel Free to Say "Hello!", Leave Comments, Offer Encouragement, Share a Funny or Related Item.
Best Wishes.
L.